Grow Therapy

Raised $150M in a Series D round, announced 5 March 2026.

Round

Grow Therapy secured a $150 million Series D led by TCV and Goldman Sachs Alternatives.

Amount
$150M
Stage
Series D
Announced
5 March 2026
Leads
TCV, Goldman Sachs Alternatives
Checked
Amount and date checked against the press source

Company

Provides technology and services for mental healthcare providers and patients

Sector
Health
Website
growtherapy.com ↗

Sources and links

Source
Grow Therapy Secures $150M Series D Led by TCV and Goldman Sachs Alternatives - HLTH news.google.com
Website
growtherapy.com ↗
MediaBoost

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost